If you made any changes in Pure these will be visible here soon.

Network

Laskey, Jennifer

  • NHS Greater Glasgow and Clyde

External person

Christine Crearie

  • NHS Greater Glasgow and Clyde

External person

Baillie, Kelly

  • NHS Greater Glasgow and Clyde

External person

Clarke, Julie

  • NHS Greater Glasgow and Clyde

External person

Olivia Wu

  • University of Glasgow
  • University of Glasgow

External person

Robert Jones

  • NHS Greater Glasgow and Clyde
  • University of Glasgow

External person

Anna Nachtnebel

  • Hauptverband der österreichischen Sozialversicherungsträger

External person

Rothe, Celia C

  • Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow

External person

Paul Hjemdahl

  • Karolinska Institutet

External person

Nadal, Cristina

  • Health Care Unit Director, Catalan Health Service

External person

Tania Schink

  • Department of Clinical Epidemiology, Leipniz Institute for Prevention Research and Epidemiology

External person

Tomas Forslund

  • Department of Healthcare Development, Stockholm Region, Public Healthcare Services Committee
  • Department of Medicine, Clinical Pharmacology Unit, Karolinska Institutet, Karolinska University Hospital Solna

External person

Ermisch, Michael

  • Pharmaceutical Department, National Association of Statutory Health Insurance Funds

External person

Tomasz Bochenek

  • Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow

External person

Wenjie Zeng

  • School of Management, Chongqing Jiaotong University
  • School of Management, Chongqing Jiaotong University, No.66 Xuefu Road, Nan'an District, Chongqing 400074, China.

External person

Steven Simoens

  • KU Leuven Department of Pharmaceutical and Pharmacological Sciences

External person

Lars Kjerpeseth

  • Chronic Diseases and Ageing, Division of Mental and Physical Health, Norwegian Institute of Public Health

External person

Robert Jones

  • NHS Greater Glasgow and Clyde
  • University of Glasgow

External person

Ulrike Haug

  • Department of Clinical Epidemiology, Leipniz Institute for Prevention Research and Epidemiology
  • Faculty of Human and Life Sciences, University of Bremen

External person

Anton Pottegard

  • Syddansk Universitet, Sweden

External person

Curi Hauegen, Renata

  • National Institute of Science and Technology for Innovation on Diseases of Neglected Populations (INCT-IDPN), Center for Technological Development in Health (CDTS), Oswaldo Cruz Foundation

External person

Malmstrom, Rickard

  • Karolinska Institute

External person

Malcolm, William

  • Public Health and Intelligence Business Unit, NHS National Services Scotland

External person

Joris Komen

  • Division of Pharmacoepidemiology and Clinical Pharmacology
  • Department of Healthcare Development, Stockholm Region, Public Healthcare Services Committee

External person

Torrent, J

  • Drug Area, Catalan Health Service

External person

B Kollhorst

  • Department of Biometry and Data Management, Leipniz Institute for Prevention Research and Epidemiology

External person

Obach, Merce

  • Drug Area, Catalan Health Service

External person

Morrison, David S.

  • University of Glasgow

External person

Ileana Mardare

  • Faculty of Medicine, Public Health and Management Department, Carol Davila Univeristy of Medicine and Pharmacy Bucharest

External person

Jennifer Laskey

  • NHS Greater Glasgow and Clyde

External person

Bruce, Rachel

  • Greater Glasgow NHS
  • University of Strathclyde
  • Strathclyde Institute of Pharmacy and Biomedical Science
  • Greater Glasgow and Clyde NHS Trust

External person

Morten Olesen

  • Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark

External person

Annemarie Voss

  • Department of Clinical Epidemiology, Leipniz Institute for Prevention Research and Epidemiology

External person

Watson, Anne

  • NHS Education for Scotland

External person

Oystein Karlstad

  • Chronic Diseases and Ageing, Division of Mental and Physical Health, Norwegian Institute of Public Health

External person

Östergren, Per Olof

  • Lund University

External person

Antony P Martin

  • University of Liverpool

External person

Olaf Klungel

  • Division of Pharmacoepidemiology and Clinical Pharmacology
  • Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark

External person

Aukje Mantel-Teeuwisse

  • Division of Pharmacoepidemiology and Clinical Pharmacology

External person

Maja Hellfritzsch

  • Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark
  • Department of Clinical Pharmacology, Aarhus University Hospital

External person

Jesper Hallas

  • Syddansk Universitet, Sweden

External person

Caridad Pontes

  • Barcelona Health Region, Catalan Health Service Barcelona, Spain.
  • Department of Pharmacology, Universitat Autonoma de Barcelona

External person

Stephen Campbell

  • University of Manchester
  • NIHR Greater Manchester Primary Care Patient Safety Translational Research Centre

External person

Kelly Baillie

  • NHS Greater Glasgow and Clyde

External person

Corinne Zara

  • Drug Area, Catalan Health Service

External person

Fiona Stewart

  • NHS Education for Scotland

External person

Jolanta Gulbinovic

  • Department of Pathology, Forensic Medicine and Pharmacology, Vilnius University, Vilnius, Lithuania

External person